Back to Top

"One of today's leaders in investor relations and shareholder services"

Category Archives: Interviews

SmallCapVoice.com small cap and micro cap CEO audio interviews with your host Stuart Smith.

Progressive Care, Inc. (RXMD)

6-20-18 SmallCapVoice Interview with Progressive Care, Inc. (RXMD)

Progressive Care, Inc. (RXMD)

S. Parikh Mars, CEO of Progressive Care Inc. called in to SmallCapVoice.com, Inc. to answer shareholder questions, discuss the impact of recent news about CVS entering the prescription delivery market, provide an update on several fronts and more. Recently, RXMD announced further growth year-over-year in both revenue and number of prescriptions filled for May 2018. The May sales figures come on the heels of some significant company announcements including the launch of a nationwide opioid marketing campaign, the purchase and installation of a new TCGRx pouch packaging system and the initial steps in developing a proprietary tele-pharmacy software.

For more information about Progressive Care, please visit the company’s website.

Connect and stay in touch with us on social media:

Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS

PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx

About Progressive Care, Inc.
Progressive Care Inc. (OTC QB: RXMD), through PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management (MTM), prescription medications to long term care facilities, and health practice risk management.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

Posted in Interviews| Tagged |

6-20-18 SmallCapVoice Interview with Auscrete Corporation (ASCKD)

John Sprovieri, President and CEO and Lee Odom Director of Investor Relations and Business Development for Auscrete Corporation (OTC Pink: ASCKD) called in to SmallCapVoice.com to discuss the efforts for the Company so far in 2018, how funds from their recent capital raise will propel the operations for the company, the goals for 2018 and much more. Recently in update to their the shareholders, ASCK addressed reverse split and the management moves made to ensure the future value of the Company and its capital structure. Currently the stock symbol has D at the end of it in reference to the split. By the company’s calculation that D will be removed by July 5th, 2018.

Visit the company blog at http://auscreteblog.com/

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

Posted in Interviews| Tagged |

6-12-18 SmallCapVoice Interview with Briacell Therapeutics Corp. (BCTXF)

Dr. Bill Williams, BriaCell’s President & CEO, called in to SmallCapVoice.com, Inc. to discuss the importance of the Company’s recent clinical findings as published in the American Society of Clinical Oncology (ASCO) Annual Meeting Proceedings. ASCO’s Annual Meeting represents the world’s largest gathering of oncology physicians, biotechnology executives, researchers, and investment analysts to discuss breakthrough clinical research and therapeutics in the field. Additionally, Dr. Williams discusses the significance of the novel mechanism of action of BriaCell’s lead product candidate, Bria-IMT™ which has been recently published in the journal of Frontiers in Immunology, the 5th most cited journal in Immunology.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

Posted in Interviews| Tagged |
NightFood Holdings Inc

5-31-18 Investor Conference Call with Nightfood Holdings, Inc. (NGTF)

NightFood Holdings Inc

Nightfood (NGTF), operates both Nightfood, Inc. and MJ Munchies, Inc.

Nightfood, Inc, “The Nighttime Snack Company”, is a snack food company dedicated to providing consumers delicious, better-for-you, sleep-friendly choices for evening snacking. According to IRI Worldwide, 44% of snack consumption occurs at night, representing a consumer spend of over $1B weekly on nighttime snacks.

Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Currently, consumer’s most popular choices are cookies, chips, ice cream, and candy. These options are generally understood to be unhealthy, and often contain ingredients and nutritional profiles that can impair sleep quality. Nightfood creates, manufactures, and distributes snacks formulated to help consumers satisfy nighttime cravings in a better, healthier, more sleep friendly way.

MJ Munchies, Inc. was recently formed as a new, wholly owned subsidiary, to exploit legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the brand name “Half-Baked”. As the legal landscape around CBD and cannabis related products continues to change and evolve, MJ Munchies will continue to explore, identify, and capitalize on opportunities clearly defined as legal. The Company believes tremendous opportunities currently exist to launch successful and compliant products in this space, and that such opportunities will continue to grow over time.

For more information, visit http://ir.nightfood.com and www.nightfood.com

Questions can be directed to investors@nightfood.com

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $875 from the company on 5-31-18 for 30 days of service.

Posted in Interviews| Tagged |
Progressive Care, Inc. (RXMD)

Progressive Care Inc. Reports Largest Single Revenue Quarter in Company History

Progressive Care, Inc. (RXMD)
  • Florida-Based Healthcare, Technology and Tele-Pharmacy Services Provider Shows 24% Increase in Prescriptions Filled
  • Reports March 2018 Revenue of $1.9M as Largest Single Month in Company History

MIAMI, May 15, 2018 (GLOBE NEWSWIRE) — Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology organization providing prescription pharmaceuticals, compounded medications, health risk management and tele-pharmacy services, today announced financial results for the quarter ending March 31, 2018, and provided an overview of recent operational highlights along with updates on the Company’s strategies.

The Company dispensed a total of 64,000 prescriptions in Q1, a 24% increase over Q1 2017. Revenue for the month of March 2018 was the largest single month in the Company’s history, totaling $1.9 million. For the period ending March 31, 2018, Progressive Care showed net revenue of $5,147,345, which was an increase of 7.36% year-over-year. Progressive Care’s total assets were $3,846,041 as of March 31, 2018, compared to $2,581,113 as of March 31, 2017 — an increase of 49%.

The Company continues to grow its patient base by marketing to doctors’ offices and clinics who refer their patients to the pharmacy. Healthcare providers are increasingly recommending Progressive Care subsidiary PharmCo because of its high standards of patient care and attention to performance measurements and their implications. Based on the performance in the first quarter, management expects that future growth will be driven by continued expansion into new market territories, concentrated efforts toward developing our compliance and adherence services provided to medical providers, and enhancement of technological opportunities that boost loyalty and customer satisfaction.

“The first quarter was a time of momentous growth for the Company,” said S. Parikh Mars, CEO of Progressive Care Inc. “During the first three months of the year we were able to secure a Palm Beach County location, recognize record revenues and prescriptions filled, and deliver increased value to our shareholders. We believe that our unique breadth of services and expanding penetration with customers in new markets will help us maintain sustainable growth in the future.”

Mars continued: “We are proud to have achieved clarity and efficiencies this year in an industry that is very difficult to navigate. We have come a long way since December 2017, but the hardest work is still ahead.”

FIRST QUARTER 2018 HIGHLIGHTS

During the first quarter of 2018, Progressive Care Inc. achieved the following milestones and significant events:

Reported record-breaking sales and growth numbers

  • In March 2018, the Company reported $1.9 million in revenue, the largest single month in its history to date. Progressive Care also experienced increases in prescriptions filled, reporting an 18% year-over-year increase in February, 2018, and 34% increase in January, 2018, as compared to the same months last year. As a result of the Company’s four-pillar structure (expertise in healthcare, patient care, pharmaceutical management, and customer service), Progressive Care reported a record $20 million in sales in 2017.

Officially began accepting Bitcoin for pharmacy sales

  • As part of Progressive Care’s plans to evolve its retail pharmacy’s technology and operations and enhance its e-commerce platform use, the company became one of the few pharmacies in the country to enable and accept cryptocurrency for daily purchases. PharmCo, LLC will use external payment providers, such as BitPay, to process all Bitcoin payments. This will allow the pharmacy to reach more customers who are increasingly using cryptocurrencies for daily purchases.

Furthered growth and expansion plans through pharmacy acquisition  

  • The Company signed a letter of intent to acquire a Touchpoint RX pharmacy in Palm Beach County and executed definitive agreements to close in the second quarter of 2018. The acquisition will facilitate the Company’s growth plans by increasing the delivery radius into Martin County, which includes Jupiter and Stuart, and will decrease costs of expansion and increase prescription dispensing efficiency.

Investor analyst upgraded Company’s price target to $0.35 per share

  • As a result of the Company’s significant progress with license applications in new markets, expansion in Palm Beach, and continued innovations in tele-pharmacy and the acceptance of Bitcoin for payment, SeeThruEquity initiated updated coverage and increased its price target to $0.35 per share.

Maintained steady investor relations activity  

  • The Company actively communicated with its customers and shareholders through various investor announcements and also maintained a presence at industry events. These efforts included:
    • Released an open letter to shareholders from the Company’s Chief Executive Officer, S. Parikh Mars, in January, 2018, highlighting significant achievements, key highlights in 2017, and a forward-looking statement for opportunities in 2018
    • Provided a progress report and outlook for investors in an audio interview with SmallCapVoice.com to discuss the business model, current market, achievements and goals for the Company
    • Company CEO S. Parikh Mars participated in an interview with Everett Jolly on Uptick Newswire’s “Stock Day” Podcast to discuss its uplisting to the OTCQB

FIRST QUARTER 2018 FINANCIAL RESULTS

Net Revenue: For the period ending March 31, 2018, Progressive Care showed net revenue of $5,147,345, as compared to revenue of $4,794,376 for the period that ended March 31, 2017, an increase of 7.36%.

Balance Sheet: Total Assets for the company were $3,846,041 as of March 31, 2018, compared to $2,581,113 as of March 31, 2017, an increase of 49%.

Net Cash Provided by Operating Activities: Operating cash flow increased from $-8,641 to $309,827 year-over-year, which is an increase of over 3,000%.

For more information about Progressive Care, please visit the company’s website. Additional commentary on the company and the industry as a whole can be found on the Progressive Care blog.

About Progressive Care, Inc. 
Progressive Care, Inc. (RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

Public Relations Contact: 
Tory Patterson, CMW Media 
Public Relations Consultant 
Tory@cmwmedia.com 
www.cmwmedia.com

Investor Relations Contact: 
Armen Karapetyan, Progressive Care 
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com

Posted in Interviews| Tagged |

5-14-18 SmallCapVoice Interview with Good Gaming, Inc. (GMER)

David B. Dorwart called in to SmallCapVoice.com, Inc. to go over the recent news and highlights for the Company here in the spring of 2018. In April, the Company announced that it has received confirmation for its uplisting to the OTCQB platform. The Company also outlined impressive growth to date in its April update to its shareholders.

Good Gaming (OTCQB: GMER) is a leading competitive gaming and social network platform targeting over 250 million esports players and participants worldwide who want to communicate with each other, develop strategies, and compete at novice, competitive and professional levels. Good Gaming has taken a strategic multifaceted approach in the esports industry with products and services ranging from multiple minecraft servers, a proprietary tournament platform, high school esports leagues and soon to come virtual reality centers. The esport industry continues to experience exponential growth going from $500 million to $1.2 billion over the last two years while industry analysts forecast a $5 billion global industry by 2020. Good Gaming seeks to create and exploit opportunities as the industry allows.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $2,500 from a third party on behalf of the issuer on 5-10-18 for 30 days of service.

Posted in Interviews| Tagged |